iTonic Holdings Ltd. (ITOC)

Market Cap	20.85M +139.1%
Revenue (ttm)	556,430 +82.3%
Net Income	-8.92M
EPS	-3.21
Shares Out	7.32M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,731
Open	3.080
Previous Close	3.000
Day's Range	2.840 - 3.090
52-Week Range	2.330 - 18.400
Beta	2.79
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 19, 2027

About ITOC

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company’s proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to prot...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 5, 2024
• Employees: 7
• Stock Exchange: Nasdaq
• Ticker Symbol: ITOC
• Website: https://www.ftzy.com.cn

Financial Performance

In 2025, iTonic Holdings's revenue was $523,031, an increase of 16.70% compared to the previous year's $448,196. Losses were -$5.10 million, 671.7% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 30, 2026

Data Sources Report a data error